登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《Science，2月28日，The United States badly bungled coronavirus testing—but things may soon improve》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-02-29

  • Speed is critical in the response to COVID-19. So why has the United States been so slow in its attempt to develop reliable diagnostic tests and use them widely?

    The World Health Organization (WHO) has shipped testing kits to 57 countries. China had five commercial tests on the market 1 month ago and can now do up to 1.6 million tests a week; South Korea has tested 65,000 people so far. The U. S. Centers for Disease Control and Prevention (CDC), in contrast, has done only 459 tests since the epidemic began. The rollout of a CDC-designed test kit to state and local labs has become a fiasco because it contained a faulty reagent. Labs around the country eager to test more suspected cases—and test them faster—have been unable to do so. No commercial or state labs have the approval to use their own tests.

  • 原文来源：https://www.sciencemag.org/news/2020/02/united-states-badly-bungled-coronavirus-testing-things-may-soon-improve
77浏览量
原文链接
相关报告

  • 《Science，2月28日，Strategies shift as coronavirus pandemic looms》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-02-28
    • Strategies shift as coronavirus pandemic looms Jon Cohen, Kai Kupferschmidt See all authors and affiliations Science 28 Feb 2020: Vol. 367, Issue 6481, pp. 962-963 DOI: 10.1126/science.367.6481.962 The global march of COVID-19 is beginning to look unstoppable. In just the past week, a countrywide outbreak surfaced in Iran, spawning additional cases in Iraq, Oman, and Bahrain. Italy put 10 towns in the north on lockdown after the virus rapidly spread there. An Italian physician carried the virus to the Spanish island of Tenerife, a popular holiday spot for northern Europeans, and Austria and Croatia reported their first cases. Meanwhile, South Korea's outbreak kept growing explosively and Japan reported additional cases in the wake of the botched quarantine of a cruise ship.
    17浏览量
    原文链接

  • 《CDC，2月14日，Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-02-14
    • Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020 Weekly / February 14, 2020 / 69(6);166–170 On February 7, 2020, this report was posted online as an MMWR Early Release. Kristina L. Bajema, MD1,2; Alexandra M. Oster, MD3; Olivia L. McGovern, PhD1,2; Stephen Lindstrom, PhD4; Mark R. Stenger, MA5; Tara C. Anderson, DVM, PhD6; Cheryl Isenhour,, DVM2; Kevin R. Clarke, MD7; Mary E. Evans, MD8; Victoria T. Chu, MD1,4; Holly M. Biggs, MD4; Hannah L. Kirking, MD4; Susan I. Gerber, MD4; Aron J. Hall, DVM4; Alicia M. Fry, MD9; Sara E. Oliver, MD2; 2019-nCoV Persons Under Investigation In December 2019, a cluster of cases of pneumonia emerged in Wuhan City in central China’s Hubei Province. Genetic sequencing of isolates obtained from patients with pneumonia identified a novel coronavirus (2019-nCoV) as the etiology (1). As of February 4, 2020, approximately 20,000 confirmed cases had been identified in China and an additional 159 confirmed cases in 23 other countries, including 11 in the United States (2,3). On January 17, CDC and the U.S. Department of Homeland Security’s Customs and Border Protection began health screenings at U.S. airports to identify ill travelers returning from Wuhan City (4). CDC activated its Emergency Operations Center on January 21 and formalized a process for inquiries regarding persons suspected of having 2019-nCoV infection (2). As of January 31, 2020, CDC had responded to clinical inquiries from public health officials and health care providers to assist in evaluating approximately 650 persons thought to be at risk for 2019-nCoV infection. Guided by CDC criteria for the evaluation of persons under investigation (PUIs) (5), 210 symptomatic persons were tested for 2019-nCoV; among these persons, 148 (70%) had travel-related risk only, 42 (20%) had close contact with an ill laboratory-confirmed 2019-nCoV patient or PUI, and 18 (9%) had both travel- and contact-related risks. Eleven of these persons had laboratory-confirmed 2019-nCoV infection. Recognizing persons at risk for 2019-nCoV is critical to identifying cases and preventing further transmission. Health care providers should remain vigilant and adhere to recommended infection prevention and control practices when evaluating patients for possible 2019-nCoV infection (6). Providers should consult with their local and state health departments when assessing not only ill travelers from 2019-nCoV-affected countries but also ill persons who have been in close contact with patients with laboratory-confirmed 2019-nCoV infection in the United States.
    161浏览量
    原文链接